Opinion: The War on ‘Prediabetes’ Could be a Boon for Pharma—But is it Good Medicine?
8 Mar, 2019 | 06:16h | UTCThe war on ‘prediabetes’ could be a boon for pharma—but is it good medicine? – Science (free)
Related Commentary on Twitter
The case that pre-#diabetes is a questionable diagnosis, no less its treatment https://t.co/aowaKzMa3b
by @cpiller @sciencemagazine pic.twitter.com/ZlzE3dbE0a— Eric Topol (@EricTopol) March 7, 2019